This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (147)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Strategy From the DRSP Working Group

Daniel B. Jernigan, MD, MPH; Martin S. Cetron, MD; Robert F. Breiman, MD

JAMA. 1996;275(3):206-209.

Abstract
Emergence of drug-resistant Streptococcus pneumoniae (DRSP) presents a challenge to the medical and public health communities since the magnitude of the problem is not known, the clinical impact of DRSP infections is not well described, national vaccination rates are low, and antimicrobial drugs are often used excessively and inappropriately. To address the problem of DRSP, a working group sponsored by Centers for Disease Control and Prevention was formed in June 1994 consisting of public health practitioners, health care providers, and clinical laboratorians representing state and federal agencies and various professional organizations. Through periodic open meetings, the working group has developed a strategy for surveillance, investigation, prevention, and control of infections due to DRSP. The strategy focuses on (1) implementing an electronic laboratory-based surveillance (ELBS) system for reporting invasive DRSP infections and providing clinically relevant feedback to clinicians, (2) identifying risk factors and outcomes of DRSP infection, (3) increasing pneumococcal vaccination, and (4) promoting judicious antimicrobial drug use. Data received through ELBS will be used to make timely estimates of the community-specific prevalence of drug-resistant pneumococci. National, regional, and local trends will be made available to health care providers and clinicians to promote optimal antimicrobial drug use and increased vaccination in targeted areas. Once in operation, the ELBS network will be adaptable to other diseases, improving the comprehensiveness and timeliness of public health surveillance. The intended outcome of the strategy is to reduce complications of DRSP infection, such as long-term sequelae of infection, health care expenditures, morbidity, and mortality.

(JAMA. 1996;275:206-209)

Author Affiliations
From the Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Ga.

Footnotes
A complete list of the members of the DRSP Working Group appears at the end of the article.

Corresponding author: Martin S. Cetron, MD, Childhood and Respiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, MS CO9,1600 Clifton Rd, Atlanta, GA 30333. Direct electronic mail to drsp@ciddbd1.em.cdc.gov.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impact of Media Campaign to Reduce Antibiotic Use
Sriraman
AAP Grand Rounds 2008;20:26-27.
FULL TEXT  

Virtual surveillance of communicable diseases: a 20-year experience in France
Flahault et al.
Stat Methods Med Res 2006;15:413-421.
ABSTRACT  

Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004
Huang et al.
Pediatrics 2005;116:e408-e413.
ABSTRACT | FULL TEXT  

Interventions to Improve Treatment of Respiratory Infections in Ambulatory Managed-Care Patients
Raebel
The Annals of Pharmacotherapy 2005;39:699-705.
ABSTRACT | FULL TEXT  

Provider and Practice Characteristics Associated With Antibiotic Use in Children With Presumed Viral Respiratory Tract Infections
Gaur et al.
Pediatrics 2005;115:635-641.
ABSTRACT | FULL TEXT  

The Changing Face of Antibiotic Prescribing: The Mutant Selection Window
Epstein et al.
The Annals of Pharmacotherapy 2004;38:1675-1682.
ABSTRACT | FULL TEXT  

Effects of an Antibiotic Cycling Program on Antibiotic Prescribing Practices in an Intensive Care Unit
Merz et al.
Antimicrob. Agents Chemother. 2004;48:2861-2865.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial to Change Antibiotic Prescribing Patterns in a Community
Doyne et al.
Arch Pediatr Adolesc Med 2004;158:577-583.
ABSTRACT | FULL TEXT  

Antibiotic-Resistant Streptococcus pneumoniae in the Heptavalent Pneumococcal Conjugate Vaccine Era: Predictors of Carriage in a Multicommunity Sample
Finkelstein et al.
Pediatrics 2003;112:862-869.
ABSTRACT | FULL TEXT  

Reduction in Antibiotic Use Among US Children, 1996-2000
Finkelstein et al.
Pediatrics 2003;112:620-627.
ABSTRACT | FULL TEXT  

National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents
Liebowitz et al.
J. Clin. Pathol. 2003;56:344-347.
ABSTRACT | FULL TEXT  

Changing Use of Antibiotics in Community-Based Outpatient Practice, 1991-1999
Steinman et al.
ANN INTERN MED 2003;138:525-533.
ABSTRACT | FULL TEXT  

Misconceptions About Colds and Predictors of Health Service Utilization
Lee et al.
Pediatrics 2003;111:231-236.
ABSTRACT | FULL TEXT  

Trends in Antimicrobial Prescribing Rates for Children and Adolescents
McCaig et al.
JAMA 2002;287:3096-3102.
ABSTRACT | FULL TEXT  

Changes in Antibiotic Prescribing for Children After a Community-wide Campaign
Perz et al.
JAMA 2002;287:3103-3109.
ABSTRACT | FULL TEXT  

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence
Ball et al.
J Antimicrob Chemother 2002;49:31-40.
ABSTRACT | FULL TEXT  

Academic Detailing to Improve Use of Broad-Spectrum Antibiotics at an Academic Medical Center
Solomon et al.
Arch Intern Med 2001;161:1897-1902.
ABSTRACT | FULL TEXT  

Pneumococcal Virulence Factors: Structure and Function
Jedrzejas
Microbiol. Mol. Biol. Rev. 2001;65:187-207.
ABSTRACT | FULL TEXT  

Clonal Groups of Penicillin-Nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a Population-Based, Molecular Epidemiologic Study
McEllistrem et al.
J. Clin. Microbiol. 2000;38:4367-4372.
ABSTRACT | FULL TEXT  

Limiting the Spread of Resistant Pneumococci: Biological and Epidemiologic Evidence for the Effectiveness of Alternative Interventions
Schrag et al.
Clin. Microbiol. Rev. 2000;13:588-601.
ABSTRACT | FULL TEXT  

Cultural and Economic Factors That (Mis)Shape Antibiotic Use: The Nonpharmacologic Basis of Therapeutics
Avorn and Solomon
ANN INTERN MED 2000;133:128-135.
ABSTRACT | FULL TEXT  

A Novel Multiresistant Streptococcus pneumoniae Serogroup 19 Clone from Washington State Identified by Pulsed-Field Gel Electrophoresis and Restriction Fragment Length Patterns
Luna et al.
J. Clin. Microbiol. 2000;38:1575-1580.
ABSTRACT | FULL TEXT  

Antimicrobial Use in Defined Populations of Infants and Young Children
Finkelstein et al.
Arch Pediatr Adolesc Med 2000;154:395-400.
ABSTRACT | FULL TEXT  

Invasive Pneumococcal Infection in Baltimore, Md: Implications for Immunization Policy
Harrison et al.
Arch Intern Med 2000;160:89-94.
ABSTRACT | FULL TEXT  

Fever in Pediatric Primary Care: Occurrence, Management, and Outcomes
Finkelstein et al.
Pediatrics 2000;105:260-266.
ABSTRACT | FULL TEXT  

Bacterial Infections in Infants 60 Days and Younger: Epidemiology, Resistance, and Implications for Treatment
Sadow et al.
Arch Pediatr Adolesc Med 1999;153:611-614.
ABSTRACT | FULL TEXT  

Streptococcus pneumoniae Carriage in Children Attending 59 Canadian Child Care Centers
Kellner et al.
Arch Pediatr Adolesc Med 1999;153:495-502.
ABSTRACT | FULL TEXT  

Decreasing Antibiotic Use in Ambulatory Practice: Impact of a Multidimensional Intervention on the Treatment of Uncomplicated Acute Bronchitis in Adults
Gonzales et al.
JAMA 1999;281:1512-1519.
ABSTRACT | FULL TEXT  

Revaccination of High-Risk Adults With Pneumococcal Polysaccharide Vaccine
Nichol
JAMA 1999;281:280-281.
FULL TEXT  

Current Attitudes Regarding Use of Antimicrobial Agents: Results from Physicians' and Parents' Focus Group Discussions
Barden et al.
CLIN PEDIATR 1998;37:665-671.
ABSTRACT  

National Trends in the Use of Antibiotics by Primary Care Physicians for Adult Patients With Cough
Metlay et al.
Arch Intern Med 1998;158:1813-1818.
ABSTRACT | FULL TEXT  

Three-Year Multicenter Surveillance of Systemic Pneumococcal Infections in Children
Kaplan et al.
Pediatrics 1998;102:538-545.
ABSTRACT | FULL TEXT  

Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis
Fernandez et al.
Antimicrob. Agents Chemother. 1998;42:1517-1519.
ABSTRACT | FULL TEXT  

Antibiotic Prescribing for Children With Colds, Upper Respiratory Tract Infections, and Bronchitis
Nyquist et al.
JAMA 1998;279:875-877.
ABSTRACT | FULL TEXT  

Low Dosage and Long Treatment Duration of {beta}-Lactam: Risk Factors for Carriage of Penicillin-Resistant Streptococcus pneumoniae
Guillemot et al.
JAMA 1998;279:365-370.
ABSTRACT | FULL TEXT  

Antibiotic Prescribing and Respiratory Tract Infections
Jacques et al.
JAMA 1998;279:271-273.
FULL TEXT  

Principles of Judicious Use of Antimicrobial Agents for Pediatric Upper Respiratory Tract Infections
Dowell et al.
Pediatrics 1998;101:163-165.
ABSTRACT | FULL TEXT  

Does This Patient Have Community-Acquired Pneumonia? Diagnosing Pneumonia by History and Physical Examination
Metlay et al.
JAMA 1997;278:1440-1445.
ABSTRACT  

Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer et al.
Proc. Natl. Acad. Sci. USA 1997;94:12106-12111.
ABSTRACT | FULL TEXT  

Antibiotic Prescribing for Adults With Colds, Upper Respiratory Tract Infections, and Bronchitis by Ambulatory Care Physicians
Gonzales et al.
JAMA 1997;278:901-904.
ABSTRACT  

Medical Outcomes and Antimicrobial Costs With the Use of the American Thoracic Society Guidelines for Outpatients With Community-Acquired Pneumonia
Gleason et al.
JAMA 1997;278:32-39.
ABSTRACT  

Ceftriaxone for Acute Otitis Media
Eppes et al.
Pediatrics 1997;100:157-157.
FULL TEXT  

Infection Emergent
Lederberg
JAMA 1996;275:243-245.
ABSTRACT